Mercado de terapia del cáncer de páncreas: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPMD00002009
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 133
Buy Now

[Informe de investigación] Se espera que el mercado de la terapia del cáncer de páncreas alcance los 4.056,4 millones de dólares en 2025, frente a los 2011,2 millones de dólares de 2017; se estima que crecerá a una tasa compuesta anual del 8,1% entre 2018 y 2025.
El cáncer de páncreas comienza cuando las células del páncreas crecen sin control. Según el tipo de célula afectada, el cáncer de páncreas se puede clasificar en dos tipos, tumores exocrinos y tumores endocrinos. Estos tumores se comportan de manera diferente. Por eso se les trata de manera diferente. El cáncer de páncreas generalmente se diagnostica en una etapa posterior, ya que los síntomas no se detectan ni diagnostican fácilmente. Factores como la inflamación crónica del páncreas (pancreatitis), la diabetes, el tabaquismo y la obesidad son algunas de las causas identificadas del cáncer de páncreas. El crecimiento del mercado de terapias contra el cáncer de páncreas se atribuye a factores como el aumento del número de pacientes que padecen cáncer de páncreas, el aumento de los gastos sanitarios en medicamentos pancreáticos y el aumento del número de terapias lanzadas al mercado. Además, se espera que el desarrollo de una terapia eficaz para el tratamiento del cáncer de páncreas estimule el mercado durante el período de previsión. Sin embargo, se espera que los efectos secundarios de las terapias y la baja tasa de éxito de los tratamientos limiten el mercado de la terapia del cáncer de páncreas.

Mercados regionales lucrativos para la terapia del cáncer de páncreas


Perspectivas del mercado

Aumento en el número de pacientes que padecen cáncer de páncreas

El cáncer de páncreas es uno de los cánceres agresivos que se originan en los tejidos del páncreas y se propaga rápidamente a los órganos cercanos. El cáncer de páncreas es el duodécimo cáncer más frecuente en el mundo. Según la Sociedad Estadounidense del Cáncer, se espera que ~55,440 pacientes en los EE. UU. sean diagnosticados con cáncer de páncreas en 2018. Además, la ACS también informa que el cáncer de páncreas es la tercera causa principal de muerte relacionada con el cáncer en los EE. UU. y se espera que aumente. será la segunda causa de muerte en 2020. Según Cancer Research UK, en 2015 se diagnosticaron aproximadamente 9.921 nuevos casos de cáncer de páncreas en el Reino Unido, mientras que 8.912 pacientes murieron debido al mismo cáncer. El cáncer casi siempre es fatal y, por lo tanto, exige terapias potenciales para los pacientes. tratamiento. Por ejemplo, la Sociedad Estadounidense del Cáncer sugiere que el cáncer de páncreas representa aproximadamente el 3% de las muertes por cáncer en los EE. UU. Según el Instituto Nacional de Salud, se estima que en 2015 68.615 pacientes vivían con cáncer de páncreas en Estados Unidos. Se espera que la creciente incidencia y prevalencia del cáncer de páncreas aumente la demanda de medicamentos, terapias y tratamiento de los pacientes. Además, el creciente número de pacientes da como resultado avances en la biología molecular y la formulación química de fármacos. Por lo tanto, se espera que un gran grupo de pacientes con cáncer de páncreas aumente el crecimiento del mercado mundial de terapias contra el cáncer de páncreas durante los años previstos.

Type Insights

Según el tipo, el mercado de la terapia del cáncer de páncreas se segmenta en cáncer de páncreas endocrino y cáncer de páncreas exocrino. En 2017, el segmento de cáncer de páncreas exocrino tuvo la mayor cuota de mercado, por tipo. Se espera que el segmento de cáncer de páncreas exocrino crezca al ritmo más rápido durante los próximos años, ya que este tipo de cáncer es el más común y el que ocurre con mayor frecuencia y, por lo tanto, se espera que tenga un grupo masivo de pacientes durante los años previstos.

Mercado mundial de terapias contra el cáncer de páncreas, por tipo: 2017 y 2025


Perspectivas sobre la terapia

Basado en la terapia, el mercado de la terapia del cáncer de páncreas se segmenta en terapia biológica, quimioterapia y otras. En 2017, el segmento de terapia biológica tuvo la mayor participación del mercado, por terapia. Además, se espera que el segmento de terapia biológica crezca al ritmo más rápido durante los próximos años debido al creciente número de nuevas inmunoterapias futuras, así como a la terapia celular dirigida que trata el cáncer sin efectos secundarios graves y tiene varios beneficios terapéuticos sobre el tratamiento convencional. quimioterapias.

Información estratégica

Las estrategias orgánicas son las adoptadas con mayor frecuencia por las empresas en el mercado de la terapia del cáncer de páncreas, lo que les permite expandir su presencia global. huellas y carteras de productos y servicios. Los actores del mercado también han adoptado estrategias orgánicas como aprobaciones de productos, ensayos clínicos y otras estrategias que les han permitido ampliar su base global de clientes, lo que también les permite mantener su marca a nivel mundial.

 

Mercado global de terapias contra el cáncer de páncreas: Por tipo

  • Cáncer de páncreas exocrino
  • Cáncer de páncreas endocrino

Mercado global de terapias para el cáncer de páncreas: Por terapia

  • Terapia biológica
  • Quimioterapia
  • Otros

Mercado global de terapia contra el cáncer de páncreas: Por geografía

  • América del Norte
    • Estados Unidos
    • Canadá
    • México
  • < li>Europa
    • Francia
    • Alemania
    • Italia
    • Reino Unido
    • España
  • Asia Pacífico (APAC)
    • China
    • India
    • Corea del Sur
    • Japón
    • Australia
  • Medio Oriente y África (MEA)
    • Sudáfrica
    • Arabia Saudita
    • EAU< /li>
  • América del Sur y Central
    • Brasil
    • Argentina
< h3> 

Perfiles de empresas

  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Amgen Inc
  • Novartis AG
  • Celgene Corporation
  • Merck & Co., Inc
  • Pharmacyte Biotech Inc
  • Clovis Oncology
  • Teva Pharmaceutical Industries Ltd
  • Pfizer Inc
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies

1. Eli Lilly and Company
2. F. Hoffmann-La Roche AG
3. Celgene Corporation
4. Amgen Inc.
5. Novartis AG
6. Pharmacyte Biotech Inc.
7. Clovis Oncology
8. Teva Pharmaceutical Industries Ltd.
9. Pfizer Inc.
10. Merck & Co., Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports